Focus Partners Wealth

Position in MRK — Merck & Co., Inc.

CIK 1542153 ST LOUIS, MO

Position in MRK

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$176,753,292

+$4,052,458 QoQ

Shares Held

1,375,512

-4.2% QoQ

Ownership

0.056%

of shares outstanding

% of Portfolio

0.35%

of 13F equity value

Holder Rank

#148

of 3,769 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 59% Shared 0% None 41%

Healthcare · as of Jun 30, 2026

Focus Partners Wealth holds $1,442,065,327 across 15 Drug Manufacturers - General names. MRK ranks #4 (12.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	1,488,289	$377,980,757
2	LLY	ELI LILLY & Co	260,045	$311,905,800
3	ABBV	AbbVie Inc.	929,566	$233,915,988
4	MRK	Merck & Co., Inc. This page	1,375,512	$176,753,292
5	AMGN	Amgen Inc	315,585	$114,279,640
6	PFE	Pfizer Inc	2,693,994	$64,871,375
7	GILD	Gilead Sciences, Inc.	475,579	$60,084,650
8	NVS	Novartis AG	235,657	$36,932,165

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$176,753,292	1,375,512	-4.2%	Shares	Sole	2026-08-12
2026-03-31	$172,700,834	1,435,704	+0.6%	Shares	Sole	2026-05-15
2025-12-31	$150,263,281	1,427,544	+15.5%	Shares	Sole	2026-02-13
2025-09-30	$103,719,518	1,235,786	+1.8%	Shares	Sole	2025-11-14
2025-06-30	$96,072,850	1,213,654	+1.9%	Shares	Sole	2025-08-14
2025-03-31	$106,919,957	1,191,176	+16.3%	Shares	Sole	2025-05-20
2024-12-31	$101,927,804	1,024,606	+1.4%	Shares	Sole	2025-05-20
2024-09-30	$114,745,907	1,010,443	+17.4%	Shares	Sole	2024-11-14
2024-06-30	$106,575,210	860,866	+8.4%	Shares	Sole	2024-08-15
2024-03-31	$104,806,301	794,288	+52.0%	Shares	Sole	2024-05-16
2023-12-31	$56,970,581	522,570	—	Shares	Sole	2024-02-15
No filing history on record for this holder in this stock.